Australia's system of HTA decision-making can be imagined as a scramble of one hundred eggs. For the therapies and other technologies that provide better patient outcomes, the review's report proposes adding more eggs to the scramble. For therapies that can deliver savings, the scramble is discarded.
The HTA Review report - 'Red Flag' number two of five
September 16, 2024 Latest NewsBioPharmaComment
Latest Video
New Stories
-
Todd Stephenson confirmed on ACT list for New Zealand election
September 14, 2026 - - Latest News -
Scandal-hit KPMG still holds $37 million in health department work
September 14, 2026 - - Latest News -
Canberra details tax changes with limited concessions for some innovators
September 14, 2026 - - Latest News -
The 'Dispatched' Week in Review Podcast - 11 September
September 11, 2026 - - Podcast -
Rare genetic motor neurone disease treatment finally reaches Australian patients
September 11, 2026 - - Latest News -
NSW pharmacists to deliver all childhood vaccines and treat more conditions under reforms
September 11, 2026 - - Latest News -
AI Health Summit 2026
September 10, 2026 - - Summit
